Recently, a technique was used to inhibit the urothelial cancer-associated 1 (UCA1) long non-protein-coding RNA by CRISPR/Cas9 to prove that the target has a role in the progression of bladder cancer [59]. The gene discussed is UCA1; the disease is urinary bladder cancer.